Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
Pharmacoepidemiology and Drug Safety|December 15, 2021
Accuracy of identifying diagnosis of moderate to severe chronic kidney disease in administrative claims dataJulie M Paik, Elisabetta Patorno, Min Zhuo, et al.Journal of the American Geriatrics Society|June 24, 2023
Common non-cardiovascular multimorbidity groupings and clinical outcomes in older adults with major cardiovascular diseaseStephanie Denise M Sison, Kueiyu Joshua Lin, Mehdi Najafzadeh, et al.The American Journal of Cardiology|September 27, 2023
Utilization of P2Y12 Inhibitors in Older Adults With ST-Elevation Myocardial Infarction and FrailtyDarae Ko, Ashvin Pande, Kueiyu Joshua Lin, et al.JAMA Internal Medicine|July 20, 2026
Initiation, Adherence, and Persistence to Guideline-Directed Medical Therapy After Heart Failure HospitalizationLily G Bessette, Jared W Magnani, Maria M Brooks, et al.JAMA Network Open|November 18, 2022
Trends in Use of Oral Anticoagulants in Older Adults With Newly Diagnosed Atrial Fibrillation, 2010-2020Darae Ko, Kueiyu Joshua Lin, Lily G Bessette, et al.JAMA Network Open|October 27, 2021
Association of Sodium-Glucose Cotransporter-2 Inhibitors With Fracture Risk in Older Adults With Type 2 DiabetesMin Zhuo, Chelsea E Hawley, Julie M Paik, et al.Journal of Medical Internet Research|February 13, 2024
Identifying Functional Status Impairment in People Living With Dementia Through Natural Language Processing of Clinical Documents: Cross-Sectional StudyJohn Laurentiev, Dae Hyun Kim, Mufaddal Mahesri, et al.American Heart Journal|September 23, 2022
Comparative effectiveness of Empagliflozin in reducing the burden of recurrent cardiovascular hospitalizations among older adults with diabetes in routine clinical careRishi J Desai, Robert J Glynn, Brendan M Everett, et al.Endocrinology, Diabetes & Metabolism|January 11, 2020
The EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study programme: Design and exposure accrual for an evaluation of empagliflozin in routine clinical careElisabetta Patorno, Mehdi Najafzadeh, Ajinkya Pawar, et al.Diabetes Care|January 26, 2021
Comparative Effectiveness and Safety of Sodium-Glucose Cotransporter 2 Inhibitors Versus Glucagon-Like Peptide 1 Receptor Agonists in Older AdultsElisabetta Patorno, Ajinkya Pawar, Lily G Bessette, et al.Pageof 4